Mounjaro awaits FDA Approval, a New Game-Changing Medication for Weight Loss Mounjaro, the next game-changing medication awaiting FDA approval to treat weight loss, is part of a promising class of…
The share price of Bliss GVS Pharma has dropped as a result of USFDA remarks Bliss GVS Pharma shares fell in early trading on March 20 after the business got…
Pfizer Recalls 4.2 Million Units of Nurtec ODT Due to Child Poisoning Risk If you suffer from migraines and use Nurtec ODT (rimegepant) as your prescription medication, you may want…
Safety concerns prompt removal of pholcodine-containing cough products Due to safety worries, some cough medications available at pharmacies over the counter are being withdrawn. Health professionals have cautioned that a…
Medicines should be sold only under direct supervision of pharmacists in retail medical stores says DGCI The Drug Controller General of India (DCGI) has written to drug controllers in all…
Glenmark's Prochlorperazine Maleate Tablets have been approved by the USFDA Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg, a generic version of GlaxoSmithKline's Compazine tablets, 5 mg and 10…
Indian pharmaceutical industry to grow at 6-8% in FY2024 despite disruptive events, says ICRA Growing financial schedule 3D arrow. Profit growth, rising chart and finance business statistic vector illustration. Successful…
Glenmark Life Sciences shares rise after announcement of Rs 21 dividend per equity share Glenmark Life Sciences dividend news 2023: A day after Mumbai-based manufacturer of active pharmaceutical ingredients Glenmark…
States issue alerts as H3N2 cases increase in India; Delhi, Maharashtra, and Karnataka issue advisories According to statistics released by the health ministry, the number of H3N2 influenza virus cases…
Torrent Pharmaceuticals' Oral-Oncology manufacturing facility receives one observation from USFDA after pre-approval inspection The US Food and Drug Administration finished Torrent Pharmaceuticals' Pre-Approval Inspection (PAI) of its Oral-Oncology manufacturing facility…
"Wegovy, Ozempic, and More: An Overview of the Newest Weight Loss Drugs on the Market The weight loss business is worth billions of dollars, and one of the most common…
Oral antiviral, Paxlovid, receives strong support for traditional approval by FDA panel Paxlovid An FDA panel suggested that nirmatrelvir-ritonavir (Paxlovid) be given full approval for the treatment of high-risk COVID-19.…
Sanofi to slash U.S. list prices of Lantus insulin by 78% Sanofi SA (SASY.PA) said on Thursday it will cut U.S. list prices for its most-prescribed insulin product, Lantus, by…
Contaminated Eyedrops from India Suspected in Deadly Outbreak Across 16 US States According to US health officials, drug-resistant bacterial contamination in eyedrops may have killed one individual and severely injured…
MSN Labs Introduces Fesobig, A Generic Medication for Urinary Incontinence in India MSN Labs Fesobig, a bioequivalent generic version of Fesoterodine Fumarate tablet, has been introduced by MSN Labs for…
Glenmark Pharmaceuticals receives final FDA approval for generic version of Pfizer's Cleocin Hydrochloride capsule Glenmark The United States Food and Drug Administration (USFDA) has granted final approval to Glenmark Pharmaceuticals…
India approves critical drug for radiological and nuclear emergencies using DRDO technology DRDO The Drugs Controller General of India (DCGI) has approved a critical drug developed using DRDO technology for…
Pfizer Acquires Seagen for $43 Billion in Bid for Oncology Leadership Position Pfizer After much deliberation, Seagen Inc. has been acquired — by Pfizer Inc. The proposed $43 billion deal…
Uzbekistan Cough Syrup Deaths: Indian Government Directs Pharmaceutical Companies to Not Use Propylene Glycol from Maya Chemtech Uzbekistan Cough Syrup Deaths: Indian Government Directs Pharmaceutical Companies to Not Use Propylene…
Following the USFDA's clearance of the Famotidine tablets, Marksans Pharma rises 2% Following the USFDA's clearance of the Famotidine tablets, Marksans Pharma rises 2% Marksans Pharma shares rose nearly 2%…
